KEGG   DRUG: Efavirenz, emtricitabine and tenofovir disoproxil
Entry
D10851            Mixture   Drug                                   

Name
Efavirenz, emtricitabine and tenofovir disoproxil;
Atripla (TN)
Product
  Generic
Component
Efavirenz [DR:D00896], Emtricitabine [DR:D01199], Tenofovir disoproxil fumarate [DR:D01982]
Remark
ATC code: J05AR06
Product: D10851<US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
RNA-directed DNA polymerase
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz
      D10851  Efavirenz, emtricitabine and tenofovir disoproxil <US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Efavirenz/ Emtricitabine/ Tenofovir Disoproxil Fumarate
    D10851  Efavirenz, emtricitabine and tenofovir disoproxil
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10851
Other DBs
CAS: 731772-50-2
PubChem: 319902651

» Japanese version   » Back

  All links  
Ontology (3)   
   KEGG BRITE (3)   
Disease (1)   
   KEGG DISEASE (1)   
Chemical substance (1)   
   PubChem (1)   
All databases (5)   

Download RDF
DBGET integrated database retrieval system